Intracranial Embolism

Subscribe to Selected New Research on Intracranial Embolism

284 relevant articles (10 outcomes, 20 trials/studies) found for this Disease

Description: Blocking of a blood vessel in the SKULL by an EMBOLUS which can be a blood clot (THROMBUS) or other undissolved material in the blood stream. Most emboli are of cardiac origin and are associated with HEART DISEASES. Other non-cardiac sources of emboli are usually associated with VASCULAR DISEASES.

Also Known As:

Brain Emboli; Cerebral Emboli; Brain Embolus; Cerebral Embolus; Emboli, Brain; Emboli, Cerebral; Embolism, Cerebral; Embolus, Brain; Embolus, Cerebral; Brain Embolism; Cerebral Embolism; Embolism, Brain; Embolism, Intracranial

Relationship Network

Disease Context: Research Results

Nervous System Diseases: 3406

Central Nervous System Diseases: 929

Brain Diseases: 1117

Cerebrovascular Disorders: 530

Intracranial Embolism and Thrombosis: 1

Intracranial Embolism: 284

Cardiovascular Diseases: 18449

Vascular Diseases: 7172

Cerebrovascular Disorders: 530

Intracranial Embolism and Thrombosis: 1

Intracranial Embolism: 284

Embolism and Thrombosis: 58

Thrombosis: 30019

Thromboembolism: 2997

Intracranial Embolism and Thrombosis: 1

Intracranial Embolism: 284

Thromboembolism: 2997

Intracranial Embolism and Thrombosis: 1

Intracranial Embolism: 284

Related Diseases

1.	Stroke (Strokes)
2.	Atrial Fibrillation
3.	Embolism (Embolus)
4.	Wounds and Injuries (Trauma)
5.	Myocardial Infarction

Experts

1.	Borger, Michael A: 2 articles (06/2005 - 03/2002)
2.	Matsubara, Shuko: 1 article (06/2008)
3.	Etou, Housei: 1 article (06/2008)
4.	Iko, Minoru: 1 article (06/2008)
5.	Sakamoto, Kimiya: 1 article (06/2008)
6.	Onizuka, Masanari: 1 article (06/2008)
7.	Kazekawa, Kiyoshi: 1 article (06/2008)
8.	Nii, Kouhei: 1 article (06/2008)
9.	Aikawa, Hiroshi: 1 article (06/2008)
10.	Tsutsumi, Masanori: 1 article (06/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Intracranial Embolism:

1.	Warfarin (Coumadin)FDA LinkGeneric 04/01/2007 - "Here, we emphasize that patients with AHCM in the dilatation phase must receive warfarin therapy to prevent cardiogenic cerebral embolism." 05/01/1995 - "Four patients with a thrombus in the left atrial appendage were identified: 1 died of cerebral embolism 3 days after the beginning of anticoagulation, in another one CV was definitely deferred because of the persistence of thrombus after 1 month of warfarin therapy" 08/01/1993 - "In order to evaluate the efficacy of warfarin for the secondary prevention of cardioembolic stroke due to nonvalvular atrial fibrillation (NVAF), we retrospectively investigated the frequencies of recurrent brain embolism and hemorrhagic complications in 68 subjects (62 +/- 9 years old, 54 men and 14 women), who had experienced at least one cardioembolic stroke prior to the study period" 05/01/1990 - "The rationale underlying contemporary clinical trials of warfarin therapy for the prevention of stroke in patients who have non-rheumatic atrial fibrillation is that the majority of strokes in such patients are due to cardiogenic cerebral embolism" 03/01/2007 - "As we considered cerebral embolism, the patient received heparin followed by warfarin" Order ALL the reference details at left...
2.	Tissue Plasminogen Activator (Alteplase)FDA Link 01/01/1992 - "METHODS: We intravenously administered recombinant tissue plasminogen activator (20-30 MU for 1 hour) to 10 patients with acute (less than 6 hours) brain embolism and examined the neurological outcomes in relation to the findings on computed tomography and angiography" 12/13/1985 - "Tissue plasminogen activator reduces neurological damage after cerebral embolism." 12/01/1991 - "To study the thrombolytic effect of tissue plasminogen activator (t-PA) on cerebral emboli, we characterized cerebral embolization in stroke-prone spontaneously hypertensive rats (SHRSPs) and Wistar Kyoto rats (WKYs)" 09/01/2002 - "Cerebral embolism complicating Libman-Sacks endocarditis--full recovery using recombinant tissue plasminogen activator." 01/01/1993 - "The authors report a case of a cerebral embolism, with a rapidly resolving course, during late fibrinolysis using tissue plasminogen activator in a patient with a posterolateral myocardial infarction" Order ALL the reference details at left...
3.	glucuronyl glucosamine glycan sulfate (Vessel)IBA 09/01/2004 - "The reason why we use TAC is that retrograde perfusion by femoral artery has a high-risk of malperfusion and cerebral embolism because of atheromatous change in aorta, and the use of the axillary artery can be troublesome because of the vessel's small diameter" 07/01/1987 - "Among the cases clinically diagnosed as cerebral emboli, the 2 confirmatory angiograms were performed early (within 48 hours), and demonstrated medium-large or large vessel filling defects" 01/01/1969 - "Angiographic diagnosis of small-vessel cerebral emboli." 10/05/1967 - "Fragment of great-vessel wall causing cerebral embolism." 10/29/1999 - "This may cause cerebral emboli, but primary stent implantation may fixate atherosclerotic material on the vessel wall and thus prevent embolization" Order ALL the reference details at left...
4.	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/01/2000 - "Although the small number of patients studied precludes statistical validity (P = 0.29), the trends suggest that antiplatelet agents provide no protection against postocclusion cerebral emboli after ECS" 10/06/1998 - "This model of cerebral embolism may allow determination of the effectiveness of new antiplatelet agents in humans." 10/01/1998 - "With addition of platelet inhibitors, the incidence of cerebral embolism dramatically dropped, as only one patient presented with transient ischemic attacks in group A (p < 0.05)" Order ALL the reference details at left...
5.	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/01/1993 - "Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model." 04/01/1995 - "We evaluated the ability of monoclonal antibodies directed against leukocyte adhesion molecules (intercellular adhesion molecule-1 [ICAM-1], CD18) to enhance the efficacy of thrombolysis in a rabbit cerebral embolism stroke model" Order ALL the reference details at left...
6.	Urinary Plasminogen Activator (Urokinase)FDA LinkGeneric 04/01/1999 - "Cerebral embolism associated with left ventricular assist device support and successful therapy with intraarterial urokinase." 04/01/1993 - "The thrombolytic effect of lumbrokinase is not as potent as urokinase in a rabbit cerebral embolism model." Order ALL the reference details at left...
7.	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/01/2001 - "The occurrence of these microembolic events within the Doppler spectrum should be influenced by antithrombotic agents of proven efficacy in these patients mainly by reducing cerebral embolism" 01/01/2002 - "Two of the problems inherent in the treatment of cerebral emboli are the narrow therapeutic time window and the severe side effects of fibrinolytic drugs" Order ALL the reference details at left...
8.	Cell Adhesion MoleculesIBA 04/01/1995 - "We evaluated the ability of monoclonal antibodies directed against leukocyte adhesion molecules (intercellular adhesion molecule-1 [ICAM-1], CD18) to enhance the efficacy of thrombolysis in a rabbit cerebral embolism stroke model" Order ALL the reference details at left...
9.	Monoclonal AntibodiesIBA 04/01/1995 - "We evaluated the ability of monoclonal antibodies directed against leukocyte adhesion molecules (intercellular adhesion molecule-1 [ICAM-1], CD18) to enhance the efficacy of thrombolysis in a rabbit cerebral embolism stroke model" Order ALL the reference details at left...
10.	tirilazadIBA 07/01/1994 - "Therapeutic efficacy of tirilazad in experimental multiple cerebral emboli: a randomized, controlled trial." 07/01/1994 - "This significant protective effect suggests that pretreatment with tirilazad may play a role in clinical situations where the risk of cerebral emboli is high, with changes in leukocyte adherence as a potential mechanism." 07/01/1994 - "CONCLUSIONS: Tirilazad pretreatment reduces neurologic deficits from multiple cerebral emboli" 07/01/1994 - "We used an experimental multiple cerebral embolism model to test whether treatment with tirilazad (U74006F), a putative inhibitor of lipid peroxidation, would improve functional outcome after multiple brain emboli" Order ALL the reference details at left...

Therapies and Procedures

1.	Arthroplasty 01/01/2008 - "Transcranial Doppler ultrasound has been used to detect cerebral emboli after hip arthroplasty" 01/01/2008 - "Cognitive function and cerebral emboli after primary hip arthroplasty." 04/01/2007 - "Cerebral embolism in patients undergoing total joint arthroplasty has an incidence rate of 0.5%" 09/01/2005 - "Cerebral emboli identified as high-intensity transient signals (HITS) occur during total knee arthroplasty (TKA)" 01/01/2003 - "Paradoxic cerebral embolism after cemented knee arthroplasty: a report of 2 cases and prophylactic option for subsequent arthroplasty." Order ALL the reference details at left...
2.	Amputation 11/01/1991 - "Good results from treatment have been reported in 84 per cent of the 137 patients reported since 1970; 3 per cent required amputation and 3 per cent had cerebral emboli" 06/03/1962 - "Survival in bilateral leg amputation with embolism of the aortic bifurcation, recent cerebral embolism and myocardial infarction.]" Order ALL the reference details at left...
3.	Microspheres (Microsphere) 06/01/2003 - "Microsphere-induced cerebral embolism elicits the widespread formation of small emboli in the ipsilateral hemisphere and subsequent neuronal loss and/or the development of multiple infarct areas in the brain, particularly in the cortex, striatum, and hippocampus" 04/01/1991 - "The symptoms gradually faded away, from the 3rd day on, after microsphere-induced cerebral embolism" 02/01/1991 - "Time course of changes in brain energy metabolism of the rat after microsphere-induced cerebral embolism." 05/02/2008 - "To define mechanisms underlying neurovascular injury following brain embolism-induced neurodegeneration, we investigated temporal and spatial pathological changes in brain microvessels up to 12 weeks after microsphere embolism (ME) induction in aged male rats" 09/01/2005 - "Microsphere embolism (ME)-induced ischemia model in rat resembles to multiple brain embolism in human with several clinical features" Order ALL the reference details at left...
4.	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/01/2005 - "RECENT FINDINGS: Several studies reviewed here have employed transcranial Doppler for detection of cerebral emboli and compared results between patients undergoing beating-heart versus conventional cardiopulmonary bypass" 12/01/2007 - "The significant risk of cerebral embolism during cardiopulmonary bypass (CPB) makes monitoring of embolic events advisable already when developing new operation and coagulation management strategies for example in CPB animal models" 06/01/2007 - "OBJECTIVE: Antegrade perfusion for type A acute aortic dissection prevents malperfusion and retrograde cerebral embolism during cardiopulmonary bypass" 02/01/2007 - "Cardiopulmonary bypass, in particular, cerebral emboli, has been implicated" 06/01/2005 - "Reducing cerebral emboli during cardiopulmonary bypass." Order ALL the reference details at left...
5.	Lasers (Laser) 07/01/1997 - "This study aimed to determine whether the laser pulse resulted in cerebral emboli and to examine changes in middle cerebral artery flow velocity and jugular bulb oxygen saturation (SjO2) during transmyocardial laser revascularization" 02/01/1998 - "Laser microprobe mass spectrometric study of aluminum and silicon in brain emboli related to cardiac surgery." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Intracranial Embolism

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 10 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>